Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma
2025 · Journal of Clinical Oncology · 12 citations
https://doi.org/10.1200/jco-25-01534
H
Hua‐Jay J. Cherng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
239
Citations
9
h-index
8
i10-index
Hua‐Jay J. Cherng is an academic researcher from Columbia University Irving Medical Center. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CAR-T cell therapy research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 9, co-authored 62 publications.
ORCID: 0000-0002-8266-8447Papers by this author
worksPosttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia
2025 · Blood Neoplasia · 1 citations
https://doi.org/10.1016/j.bneo.2025.100160
Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant
2025 · Blood Neoplasia · 0 citations
https://doi.org/10.1016/j.bneo.2025.100094
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat